Metraipolis › archive › dc_d3462fe1085e

PRDM16 Drives Thyroid Cancer Differentiation via a TRIM58-MVP Axis to Suppress MAPK and PI3K/AKT Signaling — Europe PMC PMID:42157931

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42157931
DOI
10.7150/ijbs.131151
License (as archived)
solo-consultazione
Archived
2026-11-03T07:56:24.615Z
SHA-256 of the archived text
492661040e8b29ca7b3b66cf4206490528c1b79714e9fca124a7ca32eecbc321
Stable URL of this page
https://metraipolis.com/documento/dc_d3462fe1085e

How to cite

PRDM16 Drives Thyroid Cancer Differentiation via a TRIM58-MVP Axis to Suppress MAPK and PI3K/AKT Signaling — Europe PMC PMID:42157931 — Europe PMC (en), https://europepmc.org/article/MED/42157931 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d3462fe1085e (Metraipolis archive dc_d3462fe1085e, sha256 492661040e8b29ca7b3b66cf4206490528c1b79714e9fca124a7ca32eecbc321)
BibTeX
@misc{dcd3462fe1085e,
  title = {PRDM16 Drives Thyroid Cancer Differentiation via a TRIM58-MVP Axis to Suppress MAPK and PI3K/AKT Signaling — Europe PMC PMID:42157931},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42157931},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d3462fe1085e; sha256 492661040e8b29ca7b3b66cf4206490528c1b79714e9fca124a7ca32eecbc321},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42157931. Agents can read the archived copy with the MCP tool read_document.